The post hoc analysis of the SURPASS study evaluated predictors of radiographic spinal progression in axial spondyloarth
Tweet Content
The post hoc analysis of the SURPASS study evaluated predictors of radiographic spinal progression in axial spondyloarthritis patients treated with IL-17A (secukinumab) or TNF inhibitors over 2 years.
Key findings:
- New syndesmophytes: 18.2% (SEC 150 mg), 15.8% (SEC 300 mg),… https://t.co/jke6OHdPjZ
Show on Archive Page
On
Display in Search Results
On
PDQ
Off